These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19419929)

  • 1. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
    Sangha R; Lara PN; Mack P; Gandara DR
    Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for advanced lung cancer.
    Blackhall F; Thatcher N
    Eur J Cancer; 2004 Nov; 40(16):2345-8. PubMed ID: 15519503
    [No Abstract]   [Full Text] [Related]  

  • 3. Bevacizumab in non-small cell lung cancer: new indication. Too many adverse effects to justify its use.
    Prescrire Int; 2009 Feb; 18(99):11. PubMed ID: 19385126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum-based second-line treatment in non-small-cell lung cancer: an old new kid on the block?
    de Lima Araújo LH; Ferreira CG
    J Clin Oncol; 2010 Jan; 28(2):e24-5; author reply e26. PubMed ID: 19933903
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
    Belani CP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
    Bergman B
    Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Established new drugs in the chemotherapy of non-small-cell lung carcinoma (NSCLC)].
    Serke M
    Dtsch Med Wochenschr; 2000 Feb; 125(8):225. PubMed ID: 10723459
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of side effects with platinum doublet chemotherapy used for treatment of non-small cell lung cancer].
    Kudo K; Nakagawa K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():542-7. PubMed ID: 25831819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological therapy in non-small-cell lung cancer (NSCLC)].
    Souquet PJ
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S53-4S56. PubMed ID: 15687996
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic treatment of bronchial cancer. Part 1: Standards].
    Serke M
    Pneumologie; 2006 Aug; 60(8):493-508. PubMed ID: 16933193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies.
    Gridelli C
    J Clin Oncol; 2008 Jan; 26(1):13-5. PubMed ID: 18165633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Benefits of chemotherapy of inoperable non-small cell bronchial cancers].
    Trédaniel J; Lepage E; Marty M; Hirsch A
    Rev Mal Respir; 1990; 7(6):493-5. PubMed ID: 2176731
    [No Abstract]   [Full Text] [Related]  

  • 14. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.
    Petrelli F; Ghilardi M; Cremonesi M; Cabiddu M; Barni S
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1455-65. PubMed ID: 19828007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?
    Herbst RS
    Clin Lung Cancer; 2008 Mar; 9(2):75-6. PubMed ID: 18501092
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy for advanced NSCLC: is platinum indispensable?].
    Pujol JL
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S16-9. PubMed ID: 15211227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy for advanced non-small-cell lung cancer: combinations without platinium derivatives].
    Pujol JL
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S17-4S19. PubMed ID: 15687988
    [No Abstract]   [Full Text] [Related]  

  • 19. Second and third line treatment in non-small cell lung cancer.
    Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
    Bunn PA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.